XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 127,284 $ 138,129
Accounts receivable, net of allowance for credit losses of $1,019 and $1,186 at March 31, 2024 and December 31, 2023, respectively 15,643 14,289
Inventory, net 6,871 7,849
Prepaid expenses and other current assets 2,291 2,604
Total current assets 152,089 162,871
Property and equipment, net 1,550 1,640
Operating lease right-of-use assets 1,297 1,458
Other noncurrent assets 624 682
Total assets 155,560 166,651
Current liabilities:    
Accounts payable 1,666 1,731
Accrued compensation 4,028 4,528
Accrued and other current liabilities 5,999 3,774
Current portion - long-term debt, net 0 2,219
Total current liabilities 11,693 12,252
Long-term debt 33,697 31,708
Other noncurrent liabilities 961 2,476
Total liabilities 46,351 46,436
Commitments and contingencies (Note 6)
Stockholders' equity:    
Preferred stock, par value of $0.001 per share; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 0 0
Common stock, par value of $0.001 per share; 200,000,000 shares authorized as of March 31, 2024 and December 31, 2024, respectively; 49,565,200 and 49,131,363 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 50 49
Additional paid-in-capital 420,215 414,956
Accumulated deficit (311,056) (294,790)
Total stockholders' equity 109,209 120,215
Total liabilities and stockholders' equity $ 155,560 $ 166,651